![AstraZeneca](https://www.adcreviews.com/wp-content/uploads/2022/07/AstraZeneca-300x200.jpeg)
AstraZeneca Acquires Teneotwo For Over $1.27 Billion
On July 5, AstraZeneca announced that it intends to acquire biotech company TeneoTwo and will receive a bispecific molecular therapy in Phase 1 clinical trials.
On July 5, AstraZeneca announced that it intends to acquire biotech company TeneoTwo and will receive a bispecific molecular therapy in Phase 1 clinical trials.